Article

A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission.

Division of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka, Kagoshima, Japan.
The Journal of pediatrics (impact factor: 4.02). 05/2010; 156(5):786-91. DOI:10.1016/j.jpeds.2009.11.042 pp.786-91
Source: PubMed

ABSTRACT To examine the characteristics of patients with Kawasaki disease (KD) presenting with only fever and cervical lymphadenopathy at admission.
The laboratory and clinical findings of patients with definite KD presenting with only fever and cervical lymphadenopathy at admission (KDiL) were compared with those of all other patients with KD.
Sixteen patients with KDiL (8.6%) and 171 patients without KDiL were examined. The patients with KDiL were significantly older (KDiL/non-KDiL: 4.9+/-2.5/2.2+/-1.9 years) and admitted earlier (3.0+/-1.2/3.9+/-1.3 days of illness) than the patients without KDiL. They also showed significantly elevated white blood cell counts and C-reactive protein levels. Patients with KDiL were treated with the same dose of intravenous immunoglobulin as the patients without KDiL but were treated slightly later and had significantly higher frequency of additional intravenous immunoglobulin treatment (38%/10%) and coronary artery abnormalities (25%/5%). After adjustment for age, white blood cell count, and day of illness at admission or first intravenous immunoglobulin administration, the presence of KDiL significantly increased the risk of being a nonresponder to IVIG treatment or development of a coronary artery abnormality.
KDiL indicates a severe form of KD associated with increased risks of additional intravenous immunoglobulin treatment and coronary artery abnormalities. Patients with KDiL may require heightened surveillance and more aggressive treatment.

0 0
 · 
0 Bookmarks
 · 
47 Views

Keywords

additional intravenous immunoglobulin treatment
 
aggressive treatment
 
C-reactive protein levels
 
cervical lymphadenopathy
 
characteristics
 
clinical findings
 
coronary artery abnormalities
 
coronary artery abnormality
 
definite KD
 
first intravenous immunoglobulin administration
 
higher frequency
 
intravenous immunoglobulin
 
IVIG treatment
 
Kawasaki disease
 
KDiL
 
KDiL/non-KDiL
 
risks
 
severe form
 
white blood cell count
 
white blood cell counts
 

Yuichi Nomura